|
IL142900A0
(en)
*
|
1999-09-03 |
2002-04-21 |
Amgen Inc |
Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
|
|
TR201901929T4
(tr)
*
|
2005-02-08 |
2019-03-21 |
Genzyme Corp |
TGFBeta'ya antikorlar.
|
|
CL2007002567A1
(es)
*
|
2006-09-08 |
2008-02-01 |
Amgen Inc |
Proteinas aisladas de enlace a activina a humana.
|
|
KR20100058509A
(ko)
*
|
2007-07-31 |
2010-06-03 |
메디뮨 엘엘씨 |
다중특이적 에피토프 결합 단백질 및 이의 용도
|
|
JP2011526792A
(ja)
*
|
2008-07-02 |
2011-10-20 |
エマージェント プロダクト デベロップメント シアトル， エルエルシー |
ＴＮＦ−αアンタゴニスト多重標的結合性タンパク質
|
|
EP2401296A1
(en)
*
|
2009-02-24 |
2012-01-04 |
Glaxo Group Limited |
Multivalent and/or multispecific rankl-binding constructs
|
|
EP2826789A1
(en)
*
|
2009-03-19 |
2015-01-21 |
Chugai Seiyaku Kabushiki Kaisha |
Antibody constant region variant
|
|
EP3202459B1
(en)
*
|
2009-09-09 |
2021-04-14 |
Acceleron Pharma Inc. |
Actriib antagonists and dosing and uses thereof for treating obesity or type 2 diabetes by regulating body fat content
|
|
CA3253628A1
(en)
*
|
2010-03-05 |
2025-11-29 |
The Johns Hopkins University |
Compositions and methods for targeted immunomodulatory antibodies and fusion proteins
|
|
AU2012375257B2
(en)
*
|
2012-03-31 |
2019-09-12 |
R-Pharm International, Limited Liability Company |
Osteoprotegerin derived composition and use thereof
|
|
CN105431453A
(zh)
*
|
2012-11-01 |
2016-03-23 |
艾伯维公司 |
稳定的双重可变结构域免疫球蛋白制剂
|
|
UY35148A
(es)
*
|
2012-11-21 |
2014-05-30 |
Amgen Inc |
Immunoglobulinas heterodiméricas
|
|
JP6594855B2
(ja)
*
|
2013-03-15 |
2019-10-23 |
ゼンコア インコーポレイテッド |
ヘテロ二量体タンパク質
|
|
TW201920262A
(zh)
*
|
2013-07-30 |
2019-06-01 |
美商再生元醫藥公司 |
抗活化素ａ之抗體及其用途
|
|
US20160075772A1
(en)
*
|
2014-09-12 |
2016-03-17 |
Regeneron Pharmaceuticals, Inc. |
Treatment of Fibrodysplasia Ossificans Progressiva
|
|
US10227411B2
(en)
*
|
2015-03-05 |
2019-03-12 |
Xencor, Inc. |
Modulation of T cells with bispecific antibodies and FC fusions
|
|
EP3274457A4
(en)
*
|
2015-03-26 |
2018-08-08 |
Acceleron Pharma Inc. |
Follistatin-related fusion proteins and uses thereof
|
|
WO2018009732A1
(en)
*
|
2016-07-08 |
2018-01-11 |
Regeneron Pharmaceuticals, Inc. |
Anti-activin a antibodies and methods of use thereof for treating pulmonary arterial hypertension
|
|
WO2018026742A1
(en)
*
|
2016-08-01 |
2018-02-08 |
Askgene Pharma Inc. |
Novel antibody-albumin-drug conjugates (aadc) and methods for using them
|
|
SI4190355T1
(sl)
*
|
2017-04-28 |
2025-02-28 |
Amgen Inc. |
Formulacije humanih protiteles proti-RANKL in postopki njihove uporabe
|
|
WO2019079762A1
(en)
*
|
2017-10-20 |
2019-04-25 |
Children's National Medical Center |
METHODS OF DISCOVERING ANTIBODIES USING TRANSCRIPTOMES AND COMPOSITIONS DERIVED THEREFROM
|
|
AU2019394364A1
(en)
*
|
2018-12-05 |
2021-06-17 |
The Council Of The Queensland Institute Of Medical Research |
Rank antagonists and uses therefor
|